NEUROONE MEDICAL TECHNOLOGIE (NMTC) Institutional Ownership Changes & 13F Activity

NEUROONE MEDICAL TECHNOLOGIE (NMTC). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q1 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Vanguard Capital Management Llc, Sio Capital Management, Llc, Vanguard Fiduciary Trust Co, Geode Capital Management, Llc, and Renaissance Technologies LLC.

InstitutionTypeChange in sharesChange Position %SharesReported stock balancePortfolio quarterFiling date
Geode Capital Management, LlcBuy+111,096+22.0%615,606$478.07KQ1 2026May 15, 2026
Xtx Topco LtdSell-42,171-49.3%43,283$33.61KQ1 2026May 15, 2026
Two Sigma Securities, LlcBuy+24,764—24,764$19.23KQ1 2026May 15, 2026
Morgan StanleySell-13,888-53.4%12,096$9.39KQ1 2026May 15, 2026
Aqr Capital Management LlcSell-13-0.1%10,420$8.09KQ1 2026May 15, 2026
Sio Capital Management, LlcSell-643,426-56.4%496,614$385.62KQ1 2026May 14, 2026
Renaissance Technologies LLCSell-107,582-14.1%655,446$508.95KQ1 2026May 14, 2026
Legato Capital Management LlcBuy+17,313+39.1%61,642$47.87KQ1 2026May 14, 2026
Mariner, LlcSell-13-0.1%10,420$8.09KQ1 2026May 13, 2026
Essex Investment Management Co LlcBuy+73,526+39.0%261,953$203.41KQ1 2026May 11, 2026
Citigroup IncBuy+975—975$757.00Q1 2026May 11, 2026
Vanguard Capital Management LlcBuy+1,397,329—1,397,329$1.09MQ1 2026May 08, 2026
Vanguard Fiduciary Trust CoBuy+292,081—292,081$226.95KQ1 2026May 08, 2026
Bard Associates IncSell-6,498-0.4%1,840,498$1.43MQ1 2026May 08, 2026
Lpl Financial LlcBuy+4,100+37.5%15,034$11.67KQ1 2026May 06, 2026
Ubs Group AgSell-1,817-94.4%108$84.00Q1 2026May 05, 2026
Belpointe Asset Management LlcBuy+75,000—75,000$58.24KQ1 2026Apr 28, 2026
Revisor Wealth Management LlcBuy+19,580—19,580$15.20KQ1 2026Apr 27, 2026
Arch Global Advisors, LlcBuy+17,434—17,434$13.54KQ1 2026Apr 15, 2026
Blair William & Co/IlSell-48,056-100.0%0$0.00Q1 2026Feb 17, 2026
Citadel Advisors LlcSell-44,294-100.0%0$0.00Q1 2026Feb 17, 2026
Tower Research Capital Llc (Trc)Sell-4,647-100.0%0$0.00Q1 2026Feb 17, 2026
Bank Of America CorpSell-463-100.0%0$0.00Q1 2026Feb 17, 2026
Mai Capital ManagementSell-50,000-100.0%0$0.00Q1 2026Feb 13, 2026
Squarepoint Ops LlcSell-47,968-100.0%0$0.00Q1 2026Feb 13, 2026
Jane Street Group, LlcSell-62,312-100.0%0$0.00Q1 2026Feb 12, 2026
Jessup Wealth Management, IncSell-2,840-100.0%0$0.00Q1 2026Feb 11, 2026
Vermillion Wealth Management, Inc.Sell-3-100.0%0$0.00Q1 2026Feb 11, 2026
Acadian Asset Management LlcSell-28,135-100.0%0$0.00Q1 2026Feb 10, 2026
Goldman Sachs Group IncSell-26,764-100.0%0$0.00Q1 2026Feb 10, 2026
Showing 30 of 30

Frequently asked questions about NMTC activity

  • Which institutional owners are buying NMTC?

    Institutional owners buying NMTC include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in NMTC activity?

    "Buy" means an investor increased their reported position in NMTC compared to the prior reporting period. This reflects growing exposure to NEUROONE MEDICAL TECHNOLOGIE (NMTC) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in NMTC increasing?

    Institutional interest in NMTC can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.